Details for 2017878604

Up to date per 03.04.2026

Actions

Title / Product Name

ALPRAZOLAM ZUR VERWENDUNG BEI DER BEHANDLUNG VON EPILEPSIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017878604

EP Publication Number

3551189

E-Number

1626443

Language

PCT Number

US17065347

Publication Date

16.10.2019 A

01.11.2023 B1

Registration Date

01.11.2023

AT Publication Date

15.11.2023

Application Date

08.12.2017

Registration Number

Priorities

09.12.2016

201662432353 P

13.04.2017

201762485281 P

IPC

A61K 31/5517 20060101AFI20200616BHEP

Maximum Duration of Protection

08.12.2037

Owner

Alexza Pharmaceuticals, Inc.2091 Stierlin Ct. Mountain View, CA 94043US

Representative

No representatives present

Inventor

CASSELLA, James7 Little Point Street Essex, Connecticut 06426US

GONG, Lily1411 Montego Drive San Jose, California 95120US

KAMEMOTO, Edwin S.585 Dory Lane Redwood City, California 94065US

Information about Fees